KA

Kumud Agarwal

Director Director DIN 00272227
DIN 00272227 First appointment Jan 1985 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 1985
Shareholding value Locked Premium profile

About Kumud Agarwal

Kumud Agarwal has 41 years in corporate governance. Formerly with 1 company, such as Sain Medicaments Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00272227
Primary Designation Director
First Appointment 01 Jan 1985
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Sain Medicaments Private Limited U24230TG1983PTC004015
Director 01 Jan 1985 1983 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sain Medicaments Private Limited
Premium access

Shareholding and investment profile for Kumud Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumud Agarwal

Kumud Agarwal has 41 years in corporate governance. Formerly with 1 company, such as Sain Medicaments Private Limited. Engaged in General Business. Contributes to corporate operations.

Kumud Agarwal is associated with 0 companies as a director.

Kumud Agarwal has expertise in General Business.

Kumud Agarwal has 41 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available